Jung HY - Search Results

1

Association study of TP53 polymorphisms with lung cancer in a Korean population.

Jung HY, Whang YM, Sung JS, Shin HD, Park BL, Kim JS, Shin SW, Seo HY, Seo JH, Kim YH. Jung HY, et al. J Hum Genet. 2008;53(6):508. doi: 10.1007/s10038-008-0278-y. Epub 2008 Mar 25. J Hum Genet. 2008. PMID: 18363031

2

CDK2/4 regulate retinoic acid-induced G1 arrest in hepatocellular carcinoma cells.

Jung HY, Park SH, Yoo YD, Kim JS, Kim YH. Jung HY, et al. Hepatol Res. 2005 Mar;31(3):143-52. doi: 10.1016/j.hepres.2004.12.006. Epub 2005 Feb 12. Hepatol Res. 2005. PMID: 15715961

3

Lack of association of fragile histidine triad (FHIT) polymorphisms with lung cancer in the Korean population.

Jung HY, Sung JS, Whang YM, Shin HD, Park BL, Kim JS, Shin SW, Seo HY, Sung HJ, Choi IK, Oh SC, Seo JH, Kim YH. Jung HY, et al. J Hum Genet. 2007;52(8):668. doi: 10.1007/s10038-007-0169-7. Epub 2007 Jul 4. J Hum Genet. 2007. PMID: 17609851

4

Microtubule-damaging agents enhance RASSF1A-induced cell death in lung cancer cell lines.

Whang YM, Park KH, Jung HY, Jo UH, Kim YH. Whang YM, et al. Among authors: jung hy. Cancer. 2009 Mar 15;115(6):1253-66. doi: 10.1002/cncr.24113. Cancer. 2009. PMID: 19156899 Free article.

5

A study of RET proto-oncogene polymorphisms in association with lung cancer risk in the Korean population.

Kim HK, Jung HY, Lim S, Sung JS, Whang YM, Jo U, Lee JE, Shin SW, Kim JS, Ryu JS, Kim YH. Kim HK, et al. Among authors: jung hy. Anticancer Res. 2010 Sep;30(9):3621-7. Anticancer Res. 2010. PMID: 20944145

6

An association study of polymorphisms in JAK3 gene with lung cancer in the Korean population.

Yoo W, Jung HY, Lim S, Sung JS, Park KH, Ryu JS, Shin SW, Kim JS, Seo JH, Kim YH. Yoo W, et al. Among authors: jung hy. Cancer Res Treat. 2011 Jun;43(2):108-16. doi: 10.4143/crt.2011.43.2.108. Epub 2011 Jun 30. Cancer Res Treat. 2011. PMID: 21811427 Free PMC article.

7

Can serum be used for analyzing the EGFR mutation status in patients with advanced non-small cell lung cancer?

Kim ST, Jung HY, Sung JS, Jo UH, Tanaka T, Hagiwara K, Park KH, Shin SW, Kim JS, Kim YH. Kim ST, et al. Among authors: jung hy. Am J Clin Oncol. 2013 Feb;36(1):57-63. doi: 10.1097/COC.0b013e31823a5217. Am J Clin Oncol. 2013. PMID: 22237146

8

The Blocking of c-Met Signaling Induces Apoptosis through the Increase of p53 Protein in Lung Cancer.

Jung HY, Joo HJ, Park JK, Kim YH. Jung HY, et al. Cancer Res Treat. 2012 Dec;44(4):251-61. doi: 10.4143/crt.2012.44.4.251. Epub 2012 Dec 31. Cancer Res Treat. 2012. PMID: 23341789 Free PMC article.

9

RASSF1A Suppresses Cell Migration through Inactivation of HDAC6 and Increase of Acetylated α-Tubulin.

Jung HY, Jung JS, Whang YM, Kim YH. Jung HY, et al. Among authors: jung js. Cancer Res Treat. 2013 Jun;45(2):134-44. doi: 10.4143/crt.2013.45.2.134. Epub 2013 Jun 30. Cancer Res Treat. 2013. PMID: 23864847 Free PMC article.

10

Correlation between Retinoic Acid Sensitivity and IGFBP-3, AFP Protein Expression in Hepatoma Cell Lines.

Jung HY, Lee YM, Yoo YD, Kim JS, Park SH, Kim YH. Jung HY, et al. Cancer Res Treat. 2003 Feb;35(1):59-65. doi: 10.4143/crt.2003.35.1.59. Cancer Res Treat. 2003. PMID: 26680915

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,422 results

Search Page

Filters